OncoRes Medical Raises Funding to Advance Elora Clinical Development

Monday, 13 February 2026 / Salong Debbarma / Medical Device Network 

The Elora probe generates micro-scale 3D maps of mechanical and optical properties following excision during BCS. Credit: Maria Sbytova / Shutterstock.com.

Excerpt from article:

Australia-based OncoRes Medical has completed A$27m($19.1m) private funding round to support the clinical development and regulatory advancement of its quantitative micro-elastography (QME) imaging system, Elora.

The funding round saw participation from Brandon Capital Partners’ BB6 Fund, Radar Ventures, Morgans, The Table Club network, and Australian and international family offices.

Elora delivers real-time analysis of tumours, enabling surgeons to identify and excise cancerous tissue with accuracy. It is designed to enhance outcomes in breast-conserving surgery (BCS) and may cut the frequency of repeat procedures for breast cancer patients.

This article was first published by Medical Device Network. Click here for full article.